Call for Abstract
Scientific Program
4th World Congress on Virology, will be organized around the theme “Anti-Viral Immunity and Countermeasures to Control Disease Pathogenesis”
Virology-2014 is comprised of 15 tracks and 93 sessions designed to offer comprehensive sessions that address current issues in Virology-2014.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1General viral science
- Track 1-2Viral genetics and transmission
- Track 1-3Genomics and proteomics of viruses
- Track 1-4Viral replication mechanisms
- Track 2-1New strategies for anti-viral agents
- Track 2-2Viral threat breakout prediction and measures
- Track 2-3Epidemiology of emerging viruses
- Track 2-4Prevention and measures to curb viral breakouts
- Track 2-5Viral evolution
- Track 3-1Human papilloma virus
- Track 3-2Rabies
- Track 3-3Rubella
- Track 3-4Mumps and measles
- Track 3-5Japanese encephalitis
- Track 3-6Rotavirus
- Track 3-7Hand, foot and mouth diseases
- Track 3-8Combating viral diseases in Afro-Asian continents
- Track 4-1Systems biology in HIV, METH and cART
- Track 4-2HIV diagnosis
- Track 4-3HIV and retroviral transmission and prevention
- Track 4-4Anti-retroviral therapies and associated complications
- Track 4-5Psychological and social issues associated with HIV
- Track 4-6Opportunistic diseases in HIV
- Track 4-7Immunology of HIV and retroviral infections
- Track 4-8Clinical trials in HIV AIDS
- Track 4-9Nucleoside analogues
- Track 4-10HIV vaccines and advances
- Track 4-11Molecular mechanisms and novel targets
- Track 5-1Viral gastroenteritis
- Track 5-2Hepatocellular carcinomas
- Track 5-3HPV associated cervical cancers
- Track 5-4Human herpes virus and cancers
- Track 5-5Simian virus 40
- Track 5-6Other cancer associated viral infections
- Track 6-1Influenza A (H1N1)
- Track 6-2Severe acute respiratory syndrome
- Track 6-3Avian flu (H5N1)
- Track 6-4Dengue virus
- Track 6-5Hanta virus
- Track 6-6Ebola virus
- Track 6-7West nile virus
- Track 7-1DNA vaccines
- Track 7-2Interleukin immune therapy
- Track 7-3Antibody therapy against viruses
- Track 7-4Gene therapy for viral infections
- Track 7-5Viral vaccines
- Track 7-6Vaccine allergy
- Track 7-7Antiviral drugs and adjuvants
- Track 7-8Safety evaluation of viral vaccines
- Track 7-9Antigen presenting cell-targeted therapy
- Track 8-1Hepatitis A
- Track 8-2Hepatitis B
- Track 8-3Hepatitis C
- Track 8-4Hepatitis D
- Track 8-5Hepatitis E
- Track 8-6Epidemiology hepatitis
- Track 8-7Hepatitis virology and immunology
- Track 9-1Viral immune evasion
- Track 9-2Receptors and signalling
- Track 9-3Neutralizing antibodies
- Track 9-4Adjuvants and cell-based immunity
- Track 9-5Prophylactic and therapeutic vaccines
- Track 10-1Neurological disorders by viruses
- Track 10-2Molecular diagnosis of nervous system viruses
- Track 10-3Neuropathogenesis
- Track 10-4AIDS associated neural diseases
- Track 11-1Plant virus epidemiology, ecology and evolution
- Track 11-2Viral vector biology and transmission
- Track 11-3Wheat and rice viruses
- Track 11-4Vegetable viruses
- Track 11-5Tobacco virus
- Track 11-6Grape vine leaf roll viral disease
- Track 11-7Virus resistant plants and disease control
- Track 11-8Biotechnology in plant viral diseases
- Track 11-9Viral mediated plant transformations
- Track 12-1Zoonotic, vector-borne and emerging diseases of veterinary importance
- Track 12-2Viroid and prion diseases
- Track 12-3Functional genomics and proteomics of animal viruses
- Track 12-4Animal vaccines and viral immunology
- Track 13-1Impact on bacterial genome evolution
- Track 13-2Phage therapy and its applications
- Track 13-3Clinical trials in phage therapy
- Track 13-4Novel anti-phage mechanisms in bacteria
- Track 14-1Bioinformatics in drug discovery
- Track 14-2Drug-Drug interactions
- Track 14-3Lead targets in drug discovery
- Track 14-4Antiviral drug resistance
- Track 14-5Virus-Drug interactions
- Track 15-1Stem cell therapy for viral infections: Promises and challenges
- Track 15-2New strategies to combat flu viruses
- Track 15-3Strain identification assays and rapid diagnostic testing for viral infections
- Track 15-4Clinical virology
- Track 15-5Viruses and nanotechnology